Cell Signaling Technology

p38 alpha MAPK (L53F8) Mouse Monoclonal Antibody (BSA and Azide Free)

#31726 · $865

32
Citing papers
755
Combined citations
Supplier page Find this product

Research areas

Cancer Cells and Metastasis9Cancer Immunotherapy and Biomarkers8Peroxisome Proliferator-Activated Receptors4Cancer Genomics and Diagnostics3Ubiquitin and proteasome pathways3Immune cells in cancer2Cell Adhesion Molecules Research2Cancer therapeutics and mechanisms2

Papers citing this product

1
The Scaffolding Adapter Gab1 Mediates Vascular Endothelial Growth Factor Signaling and Is Required for Endothelial Cell Migration and Capillary Formation
Journal of Biological Chemistry·2006·102 cit.·DOI
2
PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system<b>?</b>
OncoImmunology·2017·78 cit.·DOI
3
PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer
Cancers·2019·77 cit.·DOI
4
GAREM, a Novel Adaptor Protein for Growth Factor Receptor-bound Protein 2, Contributes to Cellular Transformation through the Activation of Extracellular Signal-regulated Kinase Signaling
Journal of Biological Chemistry·2009·49 cit.·DOI
5
Ononin ameliorates inflammation and cartilage degradation in rat chondrocytes with IL-1β-induced osteoarthritis by downregulating the MAPK and NF-κB pathways
BMC Complementary Medicine and Therapies·2022·47 cit.·DOI
6
PPARα-dependent Insig2a overexpression inhibits SREBP-1c processing during fasting
Scientific Reports·2017·46 cit.·DOI
7
Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter
Cancer Science·2018·42 cit.·DOI
8
GPRC5A deficiency leads to dysregulated MDM2 via activated EGFR signaling for lung tumor development
International Journal of Cancer·2018·39 cit.·DOI
9
Dynamic monitoring of PD‐L1 and Ki67 in circulating tumor cells of metastatic non‐small cell lung cancer patients treated with pembrolizumab
Molecular Oncology·2022·35 cit.·DOI
10
Redundant Roles for Met Docking Site Tyrosines and the Gab1 Pleckstrin Homology Domain in InlB-Mediated Entry of <i>Listeria monocytogenes</i>
Infection and Immunity·2005·27 cit.·DOI

Similar products

ProductVendorPricePapers
p38 alpha MAPK AntibodyRabbitCell Signaling Technology$136100
p38 alpha MAPK (L53F8) Mouse Monoclonal AntibodyMouseCell Signaling Technology$158100
p38 alpha MAPK (5F11) Mouse Monoclonal AntibodyMouseCell Signaling Technology$158100
p38 alpha MAPK (7D6) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$158100
p38 alpha MAPK (7D6) Rabbit Monoclonal Antibody (BSA and Azide Free)RabbitCell Signaling Technology$8654